Evidence map›Paper›PMID 26694817›Full record

ArticleBMC biology2015

iCLIP identifies novel roles for SAFB1 in regulating RNA processing and neuronal function.

Caroline Rivers, Jalilah Idris, Helen Scott, Mark Rogers, Youn-Bok Lee, Jessica Gaunt, Leonidas Phylactou, Tomaz Curk, Colin Campbell, Jernej Ule and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. RNA mCell research · 2021
    Article
  12. Review
  13. Article
  14. Scaffold association factor B (SAFB) is required for expression of prenyltransferases and RAS membrane association.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Caroline RiversRegenerative Medicine Laboratories, School of Clinical Sciences, Cellular & Molecular Medicine, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. mdcar@bristol.ac.uk.
Jalilah IdrisRegenerative Medicine Laboratories, School of Clinical Sciences, Cellular & Molecular Medicine, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. ji1569@bristol.ac.uk.
Helen ScottRegenerative Medicine Laboratories, School of Clinical Sciences, Cellular & Molecular Medicine, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. anhls@bristol.ac.uk.
Mark RogersIntelligent Systems Laboratory, Department of Engineering & Mathematics, Merchant Venturers Building, University of Bristol, Bristol, BS8 1UB, UK. mark.rogers@bristol.ac.uk.
Youn-Bok LeeMRC Centre for Neurodegeneration Research, King's College London, Institute of Psychiatry, London, UK. younbok.lee@kcl.ac.uk.
Jessica GauntRegenerative Medicine Laboratories, School of Clinical Sciences, Cellular & Molecular Medicine, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. jessica.gaunt@bristol.ac.uk.
Leonidas PhylactouFaculty of Computer and Information Science, University of Ljubljana, Trzaska cesta 25, SI-1001, Ljubljana, Slovenia. laphylac@cing.ac.cy.
Tomaz CurkThe Cyprus Institute of Neurology & Genetics, PO Box 23462, 1683, Nicosia, Cyprus. tomaz.curk@fri.uni-lj.si.
Colin CampbellInstitute of Medical Sciences & Technology, University of Kuala Lumpur, Kuala Lumpur, 43000, Malaysia. campbell@bristol.ac.uk.
Jernej UleDepartment of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. j.ule@ucl.ac.uk.
Michael NormanRegenerative Medicine Laboratories, School of Clinical Sciences, Cellular & Molecular Medicine, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. m.r.norman@bristol.ac.uk.
James B UneyRegenerative Medicine Laboratories, School of Clinical Sciences, Cellular & Molecular Medicine, Medical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. james.uney@bristol.ac.uk.
University of Bristol · GBCyprus Institute of Neurology and Genetics · CYKing's College London · GBUniversity College London · GBUniversity of Kuala Lumpur · MYUniversity of Ljubljana · SI

Funding

Biotechnology and Biological Sciences Research Council BB/F022298/1Biotechnology and Biological Sciences Research Council BB/J016489/1Wellcome Trust 089583
6 · The paper itself

Abstract

backgroundSAFB1 is a RNA binding protein implicated in the regulation of multiple cellular processes such as the regulation of transcription, stress response, DNA repair and RNA processing. To gain further insight into SAFB1 function we used iCLIP and mapped its interaction with RNA on a genome wide level.

resultsiCLIP analysis found SAFB1 binding was enriched, specifically in exons, ncRNAs, 3' and 5' untranslated regions. SAFB1 was found to recognise a purine-rich GAAGA motif with the highest frequency and it is therefore likely to bind core AGA, GAA, or AAG motifs. Confirmatory RT-PCR experiments showed that the expression of coding and non-coding genes with SAFB1 cross-link sites was altered by SAFB1 knockdown. For example, we found that the isoform-specific expression of neural cell adhesion molecule (NCAM1) and ASTN2 was influenced by SAFB1 and that the processing of miR-19a from the miR-17-92 cluster was regulated by SAFB1. These data suggest SAFB1 may influence alternative splicing and, using an NCAM1 minigene, we showed that SAFB1 knockdown altered the expression of two of the three NCAM1 alternative spliced isoforms. However, when the AGA, GAA, and AAG motifs were mutated, SAFB1 knockdown no longer mediated a decrease in the NCAM1 9-10 alternative spliced form. To further investigate the association of SAFB1 with splicing we used exon array analysis and found SAFB1 knockdown mediated the statistically significant up- and downregulation of alternative exons. Further analysis using RNAmotifs to investigate the frequency of association between the motif pairs (AGA followed by AGA, GAA or AAG) and alternative spliced exons found there was a highly significant correlation with downregulated exons. Together, our data suggest SAFB1 will play an important physiological role in the central nervous system regulating synaptic function. We found that SAFB1 regulates dendritic spine density in hippocampal neurons and hence provide empirical evidence supporting this conclusion.

conclusionsiCLIP showed that SAFB1 has previously uncharacterised specific RNA binding properties that help coordinate the isoform-specific expression of coding and non-coding genes. These genes regulate splicing, axonal and synaptic function, and are associated with neuropsychiatric disease, suggesting that SAFB1 is an important regulator of key neuronal processes.

Indexed as

Gene ExpressionRNA SplicingAlternative SplicingCD56 AntigenDown-RegulationGlycoproteinsHumansMatrix Attachment Region Binding ProteinsNerve Tissue ProteinsNuclear Matrix-Associated ProteinsReceptors, EstrogenRNA, UntranslatedUp-RegulationASTN2 protein, humanCD56 AntigenGlycoproteinsMatrix Attachment Region Binding ProteinsNCAM1 protein, humanNerve Tissue ProteinsNuclear Matrix-Associated ProteinsReceptors, EstrogenRNA, UntranslatedSAFB protein, human

Identifiers

PMID26694817
PMCPMC4689037
OpenAlexW2212385911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.